Sheeja Francis

| Apr 30, 2020 12:48 pm

Permalink

Glad to see the note on HCQ in the quidelines - "may be more beneficial than harmul in SARS-COV-2". This has been the case in my practice. I wonder if the rheumatologists in Germany prescribe a short course of HCQ for their SARS-CoV-2 patients not already taking the drug.

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×